EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In vitro genotoxicological evaluation of protein‐rich powder derived from Xanthobacter sp. SoF1

Katharina Klinzing iD, Ida Aabrandt Søndergaard, Teresa Chirom, James Whitwell, Laura Bisini, Cristina Marabottini, Fabrice Nesslany, Petri Tervasmäki, Juha-Pekka Pitkänen

Journal of Applied Toxicology · 2024

DOI: 10.1002/jat.4621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Katharina Klinzing und 8 weiteren Autor:innen. Beteiligte Einrichtung: Solar Foods Oy, Vantaa, Finland. Hauptthemen laut MEDLINE: Mutagenicity Tests, Lymphocytes, Micronucleus Tests. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Business Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One way of limiting the environmental impact of food production and improving food security is to replace part of the animal‐ or plant‐based protein in the human diet with protein sourced from microorganisms. The recently discovered bacterium Xanthobacter sp. SoF1 (VTT‐E‐193585) grows autotrophically using carbon dioxide gas as the only carbon source, yielding protein‐rich biomass that can be processed further into a powder and incorporated into various food products. Since the safety of this microbial protein powder for human consumption had not been previously assessed, its genotoxic potential was evaluated employing three internationally recognized and standardized studies: a bacterial reverse mutation test, an in vitro chromosomal aberration assay in human lymphocytes, and an in vitro micronucleus test in human lymphocytes. No biologically relevant evidence of genotoxicity or mutagenicity was found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mutagenicity TestsLymphocytesMicronucleus TestsHumansChromosome AberrationsPowdersBacterial ProteinsSalmonella typhimuriumMutagensMaleAdult

Stichwörter der Autor:innen

Xanthobacterbacterial reverse mutationchromosomal aberrationhydrogen‐oxidizing bacteriain vitro genotoxicitymicrobial proteinmicronuclei

Substanzen

PowdersBacterial ProteinsMutagens

Autor:innen und Institutionen

  • Solar Foods Oy, Vantaa, Finland.
  • Labcorp Drug Development, Harrogate, UK.
  • European Research Biology Center S.r.l. (ERBC), Rome, Italy.

ORCID-Profile: Katharina Klinzing

Förderung

  • Business Finland

Zitieren

APA

Klinzing, K., Aabrandt Søndergaard, I., Chirom, T., Whitwell, J., Bisini, L., Marabottini, C., Nesslany, F., Tervasmäki, P., & Pitkänen, J. P. (2024). In vitro genotoxicological evaluation of protein‐rich powder derived from Xanthobacter sp. SoF1. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4621

Vancouver

Klinzing K, Aabrandt Søndergaard I, Chirom T, Whitwell J, Bisini L, Marabottini C, et al. In vitro genotoxicological evaluation of protein‐rich powder derived from Xanthobacter sp. SoF1. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4621

BibTeX
@article{Klinzing2024,
  author = {Klinzing, Katharina and Aabrandt Søndergaard, Ida and Chirom, Teresa and Whitwell, James and Bisini, Laura and Marabottini, Cristina and Nesslany, Fabrice and Tervasmäki, Petri and Pitkänen, Juha-Pekka},
  title = {In vitro genotoxicological evaluation of protein‐rich powder derived from Xanthobacter sp. SoF1},
  journal = {Journal of Applied Toxicology},
  year = {2024},
  doi = {10.1002/jat.4621}
}
Kostenlos starten →